EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AATF/Che-1 RNA polymerase II binding protein overexpression reduces the anti-tumor NK-cell cytotoxicity through activating receptors modulation

Matteo Caforio, Nicola Tumino, Cristina Sorino, Isabella Manni, Stefano Di Giovenale, Giulia Piaggio, Simona Iezzi, Georgios Strimpakos, Elisabetta Mattei, Lorenzo Moretta, M Fanciulli, Paola Vacca und 2 weitere

Frontiers in Immunology · 2023

DOI: 10.3389/fimmu.2023.1191908 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Immunology, 2023. Verfasst von Matteo Caforio und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, Istituto di Ricerca e Cura a Carattere Scie…. Hauptthemen laut MEDLINE: Carrier Proteins, Neoplasms. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione AIRC per la ricerca sul cancro ETS, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

AATF/Che-1 over-expression in different tumors is well known and its effect on tumorigenicity is mainly due to its central role demonstrated in the oncogenic pathways of solid tumors, where it controls proliferation and viability. The effect exerted by tumors overexpressing Che-1 on the immune response has not yet been investigated.

Methods

Starting from ChIP-sequencing data we confirmed Che-1 enrichment on Nectin-1 promoter. Several co-cultures experiments between NK-cells and tumor cells transduced by lentiviral vectors carrying Che-1-interfering sequence, analyzed by flow-cytometry have allowed a detailed characterization of NK receptors and tumor ligands expression.

Results

Here, we show that Che-1 is able to modulate the expression of Nectin-1 ligand at the transcriptional level, leading to the impairment of killing activity of NK-cells. Nectin-1 down-modulation induces a modification in NK-cell ligands expression able to interact with activating receptors and to stimulate NK-cell function. In addition, NK-cells from Che-1 transgenic mice, confirming a reduced expression of activating receptors, exhibit impaired activation and a preferential immature status.

Discussion

The critical equilibrium between NK-cell ligand expression on tumor cells and the interaction with NK cell receptors is affected by Che-1 over-expression and partially restored by Che-1 interference. The evidence of a new role for Che-1 as regulator of anti-tumor immunity supports the necessity to develop approaches able to target this molecule which shows a dual tumorigenic function as cancer promoter and immune response modulator.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carrier ProteinsNeoplasmsAnimalsMiceLigandsMice, TransgenicNectinsRNA Polymerase IINuclear ProteinsApoptosis Regulatory Proteins

Stichwörter der Autor:innen

Che-1NK cellsNK killing activityNectin 1immune response

Substanzen

Carrier ProteinsLigandsNectinsRNA Polymerase IIAatf protein, mouseNuclear ProteinsApoptosis Regulatory Proteins

Autor:innen und Institutionen

  • Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Immunology Research Area, Innate Lymphoid Cells Unit, Bambino Gesù Children's Hospital Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Stabilimento Allevamento Fornitore e Utilizzatore (SAFU) Laboratory, Department of Research, Advanced Diagnostic, Technological Innovation, Regina Elena National Cancer Institute Istituto di Ricerca e Cura a Carattere S…
  • National Research Council (CNR), Institute of Biochemistry and Cell Biology, Monterotondo, Rome, Italy.
  • Consiglio Nazionale delle Ricerche (CNR)-Institute of Cell Biology and Neurobiology, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Fondazione Santa Lucia, Rome, Italy.
  • Tumor Immunology Unit , Children Hospital Bambino Gesù, RomaLM, Rome, Italy.

Förderung

  • Fondazione AIRC per la ricerca sul cancro ETS
  • Ministero della Salute

Zitieren

APA

Caforio, M., Tumino, N., Sorino, C., Manni, I., Di Giovenale, S., Piaggio, G., Iezzi, S., Strimpakos, G., Mattei, E., Moretta, L., Fanciulli, M., Vacca, P., Locatelli, F., & Folgiero, V. (2023). AATF/Che-1 RNA polymerase II binding protein overexpression reduces the anti-tumor NK-cell cytotoxicity through activating receptors modulation. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1191908

Vancouver

Caforio M, Tumino N, Sorino C, Manni I, Di Giovenale S, Piaggio G, et al. AATF/Che-1 RNA polymerase II binding protein overexpression reduces the anti-tumor NK-cell cytotoxicity through activating receptors modulation. Frontiers in Immunology. 2023. doi:10.3389/fimmu.2023.1191908

BibTeX
@article{Caforio2023,
  author = {Caforio, Matteo and Tumino, Nicola and Sorino, Cristina and Manni, Isabella and Di Giovenale, Stefano and Piaggio, Giulia and Iezzi, Simona and Strimpakos, Georgios and Mattei, Elisabetta and Moretta, Lorenzo and Fanciulli, M and Vacca, Paola and Locatelli, Franco and Folgiero, Valentina},
  title = {AATF/Che-1 RNA polymerase II binding protein overexpression reduces the anti-tumor NK-cell cytotoxicity through activating receptors modulation},
  journal = {Frontiers in Immunology},
  year = {2023},
  doi = {10.3389/fimmu.2023.1191908}
}
Kostenlos starten →